B.S., Psychology, Saint Joseph’s University
Emily comes to FRI from the University of Pennsylvania ID Clinical Trials Unit, where she worked on many projects focusing on virologic, immunologic, pharmacologic, clinical, and social outcomes associated with therapeutic interventions in the HIV+ population. Emily enjoyed the privilege of working with individuals from diverse backgrounds throughout her 15 years at Penn. She brings with her an eagerness to help the CJS-involved population achieve better outcomes, both in the community and upon community re-entry with emphasis on the connection between use disorders and incarceration.
Emily joined FRI as a Research Assistant to work with Dr. Jan Gryczynski and Dr. Laura Monico on EXIT-CJS, an NIDA-sponsored project through the Justice Community Opioid Innovation Network (JCOIN), a program supported by the NIH HEAL Initiative. EXIT-CJS is a multi-site, randomized trial comparing the effectiveness of two FDA-approved medications used to treat opioid use disorder among adults with criminal justice system involvement with primary focus on retention-in-study-medication-treatment outcomes.